Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
about
Lectin of Concanavalin A as an anti-hepatoma therapeutic agentLinking innate and adaptive immunity: human Vgamma9Vdelta2 T cells enhance CD40 expression and HMGB-1 secretionInduction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 proteinHigh mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptorHMGB1: endogenous danger signalingDisruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic DiseasesCirculating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateInnate Immunity and Biomaterials at the Nexus: Friends or FoesEmerging role of HMGB1 in fibrotic diseasesNovel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic reviewRole of advanced glycation end products in cellular signalingPhosphatidylserine receptors: enhancers of enveloped virus entry and infectionS100A8 and S100A9 in cardiovascular biology and diseaseRAGE: a new frontier in chronic airways diseaseDamage-associated molecular patterns in cancer: a double-edged swordHMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cellsHMGB1 loves companyMechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritisThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityHow dying cells alert the immune system to dangerSepsis: in search of cure.Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism.Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice.Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- miceAlarmins: awaiting a clinical responseHMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talkFunctional status of peripheral blood T-cells in ischemic stroke patients.Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.Anti-HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell-mediated Th17 polarization.Analysis and verification of the HMGB1 signaling pathway.Expression and effects of high-mobility group box 1 in cervical cancer.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureElevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomesThe role of high mobility group box 1 in innate immunity.High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes.High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.
P2860
Q21284430-C323E8BB-F13F-4615-8908-750ED1435D0CQ24309154-9AAA0AA5-8A27-4A50-B873-0B924652A508Q24314282-E9CACE43-A778-49FC-997D-995D407C2501Q24604370-59DE5616-F3BA-4AD9-87F2-95C338375F78Q24645232-52C7EA04-5D3F-4F46-9A3C-A1C35485E1FBQ26744644-310AB456-845A-4602-A146-BD7F1DE8F5EDQ26768480-40B54DF8-5663-474F-9554-4F479C37017BQ26777205-7F5F7D18-F8E1-4EDF-9406-8BF50925C68FQ26801604-918CE1A6-2593-4AB2-B328-8315CA14430BQ26828596-683D111D-FD05-4B14-84A7-AC19B90AD1C3Q27001023-50114ECD-1E36-4A35-B2E6-C22A85FCB77FQ27003423-C087B12A-5BA7-4368-9A60-E19344D961E1Q27015034-508A035D-AC33-47D9-A61E-F1F6E92C7758Q27024450-036EEE85-127B-49FC-BB89-DD1EB57EBCC0Q27025295-A0337A6D-DB5C-4A00-94A2-0C7101DB3696Q28067434-92129ACD-8A05-4DB6-9A0A-21653CED9DCBQ28117763-70622A16-6602-4497-9A8B-EE36D2CCD73CQ28243671-692631FD-FB19-45B5-BC94-EC413F3420B2Q28281853-A3AA1BE7-CF1B-4136-AF9B-A2B2142BED51Q28384138-9A268074-FFE4-4E3D-8D2C-075363642908Q29615501-E890DE3C-EF8E-40E0-B061-6F1F64DCE351Q30251753-33274FBA-86D7-4BCE-A67F-9AF93405697EQ30378823-83B90B9E-A6BB-4B43-88BD-5E883A477F9DQ30407392-7F3553B1-CDB2-4AB4-AE4E-E51068E06921Q30409150-E5E87FC1-7374-4B72-A3BE-EDFFA60B90EAQ30444108-BB1E111D-D713-45B3-9818-BAC27728C65CQ30523797-4CE37454-24D2-4E47-9038-FFA0B447E05AQ33381657-C5FB88C5-585E-4BDC-9FD3-1F0594905052Q33525563-85AF7440-D085-4BC5-B6AF-A90C6EF340A7Q33660646-73A6CE47-2159-4329-8516-CF2506C1BA8FQ33735752-3717D831-FCB8-4670-8EA8-AA26765602FFQ33755561-D2AB19AB-1D7C-47D9-AED3-A9FFE29341E6Q33755849-F179005A-42DD-4CF8-9300-AA39285A16D7Q33822512-508258E1-0EF3-429C-A5D2-391BEFD401EFQ33894332-BDD1821C-2F6A-49EB-8E0D-EAF97F403819Q33941549-D9517ECB-4D81-4203-9FD6-B45FF9B50109Q34153150-44B0E1F6-C7F2-4189-AC02-0F3A48D8E6C2Q34203942-CEB5399B-391C-4892-9179-C6EFE29E3A1EQ34235391-CB4A622F-E974-4DD6-B5A8-F327387EAD7CQ34238526-D2427411-03F1-4EC3-87E1-FB282DC907D4
P2860
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
description
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juni 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/06/15)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/06/15)
@nl
наукова стаття, опублікована в червні 2005
@uk
مقالة علمية (نشرت في 15-6-2005)
@ar
name
Release of high mobility group ...... dvanced glycation end products
@ast
Release of high mobility group ...... dvanced glycation end products
@en
Release of high mobility group ...... dvanced glycation end products
@nl
type
label
Release of high mobility group ...... dvanced glycation end products
@ast
Release of high mobility group ...... dvanced glycation end products
@en
Release of high mobility group ...... dvanced glycation end products
@nl
prefLabel
Release of high mobility group ...... dvanced glycation end products
@ast
Release of high mobility group ...... dvanced glycation end products
@en
Release of high mobility group ...... dvanced glycation end products
@nl
P2093
P921
P3181
P1476
Release of high mobility group ...... dvanced glycation end products
@en
P2093
Angelo A. Manfredi
Barbara Valentinis
Bernd Arnold
Ingrid E. Dumitriu
Marco E. Bianchi
Martin Herrmann
Paramita Baruah
Peter P. Nawroth
Reinhard E. Voll
P304
P3181
P356
10.4049/JIMMUNOL.174.12.7506
P407
P577
2005-06-15T00:00:00Z